EP Patent

EP2775921A1 — Method of quantifying cancer treatment

Assigned to Exelixis Inc · Expires 2014-09-17 · 12y expired

What this patent protects

This invention is directed to a method for quantifying cancer treatment response in patients with bone metastases using computer aided bone scan assessment, comprising: (a) obtaining a bone scan image; (b) normalizing the obtained bone scan image to identify normalized bone scan …

USPTO Abstract

This invention is directed to a method for quantifying cancer treatment response in patients with bone metastases using computer aided bone scan assessment, comprising: (a) obtaining a bone scan image; (b) normalizing the obtained bone scan image to identify normalized bone scan lesions; and (c) quantitatively assessing the normalized bone scan lesions using bone scan lesion area, bone scan intensity, or bone scan lesion count.

Drugs covered by this patent

Patent Metadata

Patent number
EP2775921A1
Jurisdiction
EP
Classification
—
Expires
2014-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Exelixis Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.